New device offers a convenient way to monitor compressed air for viable particles
Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device.
Cherwell Laboratories has augmented its range of microbial air samplers with the addition of the SAS Super Pinocchio CR. This new air sampling device offers a more convenient way to monitor for viable particles in compressed air and other gas supplies used in controlled environments.
This updated version of the Pinocchio II compressed air sampling device can be fully dismantled for easy cleaning and decontamination — a process made more simple and effective by the device being manufactured in stainless-steel.
The Pinocchio CR provides a controlled method for bioburden monitoring of compressed air and other gases and can be included in an environmental monitoring program. It is ideal for use in manufacturing facilities where compressed air monitoring is falling under increasing regulatory scrutiny.
To ensure continuity with other environmental monitoring programs, the Pinocchio CR uses the same method of active air sampling as the rest of the SAS range of portable units. Using the multipoint impaction method of active sampling, air is aspirated through a perforated cover (a sampling head) and any particles present are impacted on to the agar surface of a contact plate or 90-mm Petri dish for subsequent culture.
This totally portable system, which is now more compact than the current Pinocchio II, does not require power and, therefore, can be used in high risk areas. Set up is simple as the Pinocchio CR is easily attached to an air or gas line, and a regulating valve controls the pressure delivered to the sampler. Airflow from the compressed supply is regulated through a flow meter before passing through its traditional SAS sampling head, with the unit capable of sampling 100 L/min.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance